Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 75 years old
- People who have been diagnosed with end-stage renal disease (kidney failure)
- People whose kidneys' filtering membranes move waste products into the dialysis fluid at a faster-than-average rate, based on a standard test result (confirm with trial site)
- People who are able to follow a standard peritoneal dialysis treatment routine at home
- People who have been on peritoneal dialysis for at least 3 months
- People who fully understand the study and have signed a consent form agreeing to take part
Who may not be able to join:
- People who are planning to receive a kidney transplant within the next 3 years
- People who also need hemodialysis (a different type of dialysis done at a clinic or hospital)
- People who are allergic to any ingredients in peritoneal dialysis fluid
- People who have serious heart or brain conditions, such as severe heart failure, a recent heart attack within the last 3 months, dangerous irregular heartbeats requiring treatment, dilated cardiomyopathy, or a recent stroke or brain bleed within the last 3 months
- People who have serious liver disease, such as cirrhosis, or signs of recent liver damage shown by abnormal blood test results
- People who have an active cancer or have been treated for cancer that has not fully cleared, or who have HIV infection
- Women who are pregnant, breastfeeding, or of childbearing age and who do not agree to use effective contraception during the trial
- People with a history of alcohol or illegal drug abuse
- People whose peritoneal dialysis has stopped working due to a condition called ultrafiltration failure
- People who have an intellectual disability or a mental illness
- People who currently use a specific type of dialysis fluid called icodextrin
- People who have taken part in another clinical trial in the past 3 months
- People who have had a peritoneal infection (peritonitis) in the past 3 months
- People excluded for other reasons as determined by the trial investigators
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiangmei Chen, Chinese PLA General Hospital
Phone: 86-10-66935462
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite endpoint of all-cause deaths/technical failure; Quality of life (QOL); Returning to society
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.